Buspirone Hydrochloride
Product Images NDC 53002-1017

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 53002-1017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Buspirone Hydrochloride, illustrating its molecular composition and bonding arrangement as indicated in the product data from RPK Pharmaceuticals, Inc.*

FDA Label Image

10 mg (one-third Of A Tablet) (Image 10)

Buspirone Hydrochloride 10 mg round white tablet with the score line and '10' imprint on one side. No other markings or manufacturer logos are visible on this tablet image.*

FDA Label Image

Break Tablet 30 mg (Image 11)

Buspirone Hydrochloride tablets showing the imprint "10 10 10". The image displays a white, oblong tablet held between two fingers, with the imprint visible on one side. Labeler information is not visible in the image.*

FDA Label Image

Image 2

Buspirone Hydrochloride white, capsule-shaped tablet imprinted with 'TV' on one side and '1003' on the other side. The tablet is scored and has the number '5' imprinted three times on one side. No packaging or label information is visible beyond the imprint. Manufactured by RPK Pharmaceuticals, Inc.*

FDA Label Image

Image 3

Buspirone Hydrochloride tablet with imprint '55'. The image shows a close-up of a white, oval or round tablet divided by a score line, labeled with '55' on one side. The labeler is RPK Pharmaceuticals, Inc. Product NDC 53002-1017.*

FDA Label Image

Image 4

Partial view of a white tablet with the imprint '5' visible on one side, presumably representing a 5 mg strength. The tablet has a rectangular shape with rounded edges and a score line, suggesting it may be scored for splitting. No other markings or packaging details are visible.*

FDA Label Image

Image 5

Buspirone Hydrochloride tablet imprinted with the number '5' on a white, square-shaped dose form. No additional branding or markings are visible in the image.*

FDA Label Image

Image 6

Buspirone Hydrochloride tablets, showing a white, rectangular pill with beveled edges imprinted with the number '5'. The tablet is held between fingers, highlighting the pill's size and imprint for identification. Labeler information, strength, or package details are not visible in the image.*

FDA Label Image

Image 7

Buspirone Hydrochloride white oblong tablet imprinted with 'TV' on one side and '5200 10 10 10' on the other, from RPK Pharmaceuticals, Inc. Product NDC 53002-1017.*

FDA Label Image

Image 8

Buspirone Hydrochloride tablet blister pack containing two tablets, each marked with the score and imprint '10 10'. The packaging appears as a clear plastic strip with individual compartments for each tablet. Labeler information is not visible on the packaging.*

FDA Label Image

Image 9

Buspirone Hydrochloride tablet image showing the front face with the imprint '10'. The tablet is round, white, and scored, commonly representing a 10 mg strength. The image represents a single tablet likely manufactured by RPK Pharmaceuticals, Inc.*

FDA Label Image

Label Image (Lbl530021017)

Packaging label for Buspirone Hydrochloride 10 mg tablets by RPK Pharmaceuticals, Inc. The label indicates a bottle containing 30 tablets with dosing instructions to take one tablet twice a day or as directed. The label shows the product NDC as 53002-1017 and includes standard regulatory and prescription information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.